EichorEICHOR
Condition: Fulminant Hepatic Failure Synced from ClinicalTrials.gov · August 05, 2026

Recruiting studies: Fulminant Hepatic Failure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CytOSorb TreatMent Of Critically Ill PatientS Registry
Phase N/A · 28 location(s) · CytoSorbents, Inc · NCT05146336Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Phase N/A · 9 location(s) · University Medical Center Groningen · NCT07585890F573 for Injection for the Treatment of Liver Injury/Failure
Phase 2 · 10 location(s) · Beijing Continent Pharmaceutical Co, Ltd. · NCT05689645To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose
Phase 2 · 1 location(s) · Sinew Pharma Inc. · NCT05557448ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of
NA · 1 location(s) · Institute for Clinical and Experimental Medicine · NCT07329036Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06831643
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.